Division of Health Services Research, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan.
Department of Cancer Health Services Research, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
BMC Health Serv Res. 2021 Oct 29;21(1):1180. doi: 10.1186/s12913-021-07184-8.
To elucidate the experience of patients with cancer from diagnosis to early survivorship in Japan using a nationwide questionnaire survey, and to inform the current progress of the cancer control programs.
The survey was sent to a representative sample of adult patients with cancer identified from the national database of hospital-based cancer registries. The patients' responses were compared across three groups: patients with rare cancers, patients aged < 40 years, and patients with non-rare cancers aged ≥40 years.
Of 20,488 patients invited to participate in the survey, 8935 (43.6%) responded. Respondents reported an average score of 7.9 out of 10 on global ratings of care. Patients with rare cancers experienced a longer time to diagnosis but the shortest time from diagnosis to first treatment (p < 0.05). Patients aged < 40 years rated worse for the majority of the survey items, especially on items that related to communication with medical staff and items referring to early survivorship.
The care experienced by patients with cancer in Japan varies on the basis of age group and cancer type. Efforts should be directed to ensuring prompt access to diagnostic facilities for patients with rare cancers and providing sufficient support to younger patients.
本研究通过全国性问卷调查,阐明了日本癌症患者从诊断到早期生存的体验,为了解当前癌症控制项目的进展提供了信息。
该调查向从医院癌症登记数据库中确定的代表性成年癌症患者样本发送问卷。将患者的反应与三组进行比较:罕见癌症患者、<40 岁的患者和非罕见癌症、≥40 岁的患者。
在受邀参加调查的 20488 名患者中,有 8935 名(43.6%)做出了回应。受访者报告的护理总评分平均为 10 分中的 7.9 分。罕见癌症患者的诊断时间较长,但从诊断到首次治疗的时间最短(p<0.05)。<40 岁的患者对大多数调查项目的评分较差,尤其是与医务人员沟通和早期生存相关的项目。
日本癌症患者的护理因年龄组和癌症类型而异。应努力确保为罕见癌症患者提供快速获得诊断设施的机会,并为年轻患者提供足够的支持。